Announced Wed, 8 Jul · 16:50 IST
Jagsonpal Pharma acquires 77.21% stake in Aequitas Healthcare
JAGSNPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+1.8%1-day move
₹228.80
prior close
₹231.66
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.4+0.0+1.2—+1.8+0.3-1.5-1.6-1.5-2.5————
Up moveDown movePending
AI summary
Jagsonpal Pharmaceuticals has completed the acquisition of 77.21% equity stake in Aequitas Healthcare Private Limited, falling short of the initially proposed 85% stake. The deal was previously disclosed in letters to the exchanges dated 29 June and 7 July 2026. The acquisition marks a strategic expansion of the company into the healthcare services space through majority ownership.
Likely market impact
Strengthens Jagsonpal's healthcare portfolio via majority ownership of Aequitas, though the final stake is slightly below the initially announced 85% target.